Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy

IMPORTANCE: Biomarkers for chronic traumatic encephalopathy (CTE) are currently lacking. The radiotracer fluorine F 18–labeled (18F)–flortaucipir (FTP) detects tau pathology in Alzheimer disease, and positron emission tomography (PET) with FTP shows elevated binding in individuals at risk for CTE. N...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of neurology (Chicago) 2020-04, Vol.77 (4), p.517-521
Hauptverfasser: Mantyh, William G, Spina, Salvatore, Lee, Alex, Iaccarino, Leonardo, Soleimani-Meigooni, David, Tsoy, Elena, Mellinger, Taylor J, Grant, Harli, Vandevrede, Lawren, La Joie, Renaud, Lesman-Segev, Orit, Gaus, Stephanie, Possin, Katherine L, Grinberg, Lea T, Miller, Bruce L, Seeley, William W, Rabinovici, Gil D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 521
container_issue 4
container_start_page 517
container_title Archives of neurology (Chicago)
container_volume 77
creator Mantyh, William G
Spina, Salvatore
Lee, Alex
Iaccarino, Leonardo
Soleimani-Meigooni, David
Tsoy, Elena
Mellinger, Taylor J
Grant, Harli
Vandevrede, Lawren
La Joie, Renaud
Lesman-Segev, Orit
Gaus, Stephanie
Possin, Katherine L
Grinberg, Lea T
Miller, Bruce L
Seeley, William W
Rabinovici, Gil D
description IMPORTANCE: Biomarkers for chronic traumatic encephalopathy (CTE) are currently lacking. The radiotracer fluorine F 18–labeled (18F)–flortaucipir (FTP) detects tau pathology in Alzheimer disease, and positron emission tomography (PET) with FTP shows elevated binding in individuals at risk for CTE. No study, however, has assessed the correlation between in vivo FTP PET and postmortem tau in CTE. OBJECTIVE: To assess the regional association between in vivo FTP binding and postmortem tau pathology in a patient with pathologically confirmed CTE. DESIGN, SETTING, AND PARTICIPANTS: A white male former National Football League player with 17 years of US football exposure was clinically diagnosed with traumatic encephalopathy syndrome at a neurology tertiary referral center. 18F-Fludeoxyglucose, carbon 11–labeled Pittsburgh compound B, and FTP PET were performed 52 months prior to death, and magnetic resonance imaging, 50 months prior to death. Brain images were assessed qualitatively for abnormalities blinded to autopsy data. Autopsy was performed using a neurodegenerative research protocol. The FTP standardized uptake value ratios (inferior cerebellar gray reference region) and W-score (age-adjusted z-score) maps were compared with phosphorylated tau immunohistochemical analysis with monoclonal antibody CP13. MAIN OUTCOMES AND MEASURES: Qualitative and quantitative comparisons between antemortem FTP PET and tau pathology at autopsy. RESULTS: Flortaucipir uptake was distributed in a patchy, frontotemporal-predominant pattern that overlapped with regions showing neurodegeneration on magnetic resonance imaging and hypometabolism on 18F-fludeoxyglucose PET. Pathological assessment revealed stage 4 CTE; limbic argyrophilic grain disease; stage 2 limbic-predominant, age-related transactive response DNA-binding protein 43 encephalopathy; and Braak neurofibrillary tangle stage 3. 18F-Flortaucipir W-maps matched areas of high postmortem tau burden in left fusiform and inferior temporal gyri and juxtacortical frontal white matter. High FTP W-scores with low tau burden were found in the basal ganglia, thalamus, motor cortex, and calcarine cortex. No regions with low FTP W-scores corresponded to areas with high pathological tau burden. A modest correlation, which did not reach statistical significance (ρ = 0.35, P = .17), was found between FTP standardized uptake value ratio and tau area fraction at the regional level. CONCLUSIONS AND RELEVANCE: In this patient, FTP PET fi
doi_str_mv 10.1001/jamaneurol.2019.4509
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6990867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2757865</ama_id><sourcerecordid>2333931901</sourcerecordid><originalsourceid>FETCH-LOGICAL-a455t-18430c9a158f64690531b67762c9dc0bd03bbb058a686d86ba6c180b293969773</originalsourceid><addsrcrecordid>eNpdUVuLEzEUHkRxl3X_gIgEfPGlNZlkcnkRpLS7woIFu_gYMplpJyWTjMmM0H_gz_YMXeslLznku-Sc8xXFG4KXBGPy4Wh6E9opRb8sMVFLVmH1rLguCZcLTirx_FIzdVXc5nzEcCTGjLKXxRUlCjPBq-vi585MaBuzG1MMaN27nB0Uu9jHQzJD5yzauNC4cMjIBWTQJqa-TejxK1RxrI33aOvNCZ6-ubFDWzN20ceDs4Cc0CqGvQNBg1YdfABuu2Sm3oxQrYNth874OIDm9Kp4sTc-t7dP903xuFnvVveLhy93n1efHhaGVdW4IJJRbJUhldxzxhWuKKm5ELy0qrG4bjCt6xpX0nDJG8lrwy2RuC4VVVwJQW-Kj2ffYaqhL9uGMRmvh-R6k046Gqf_RYLr9CH-0FwpLPls8P7JIMXvU5tHDUuzrfcQSJyyLimlal4wAeq7_6jHOKUA4wFLKsGwwBJY7MyyKeac2v2lGYL1nLb-k7ae09Zz2iB7-_cgF9HvbIHw-kwA9QUtRSUkgL8AbmWyyA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2389740708</pqid></control><display><type>article</type><title>Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Mantyh, William G ; Spina, Salvatore ; Lee, Alex ; Iaccarino, Leonardo ; Soleimani-Meigooni, David ; Tsoy, Elena ; Mellinger, Taylor J ; Grant, Harli ; Vandevrede, Lawren ; La Joie, Renaud ; Lesman-Segev, Orit ; Gaus, Stephanie ; Possin, Katherine L ; Grinberg, Lea T ; Miller, Bruce L ; Seeley, William W ; Rabinovici, Gil D</creator><creatorcontrib>Mantyh, William G ; Spina, Salvatore ; Lee, Alex ; Iaccarino, Leonardo ; Soleimani-Meigooni, David ; Tsoy, Elena ; Mellinger, Taylor J ; Grant, Harli ; Vandevrede, Lawren ; La Joie, Renaud ; Lesman-Segev, Orit ; Gaus, Stephanie ; Possin, Katherine L ; Grinberg, Lea T ; Miller, Bruce L ; Seeley, William W ; Rabinovici, Gil D</creatorcontrib><description>IMPORTANCE: Biomarkers for chronic traumatic encephalopathy (CTE) are currently lacking. The radiotracer fluorine F 18–labeled (18F)–flortaucipir (FTP) detects tau pathology in Alzheimer disease, and positron emission tomography (PET) with FTP shows elevated binding in individuals at risk for CTE. No study, however, has assessed the correlation between in vivo FTP PET and postmortem tau in CTE. OBJECTIVE: To assess the regional association between in vivo FTP binding and postmortem tau pathology in a patient with pathologically confirmed CTE. DESIGN, SETTING, AND PARTICIPANTS: A white male former National Football League player with 17 years of US football exposure was clinically diagnosed with traumatic encephalopathy syndrome at a neurology tertiary referral center. 18F-Fludeoxyglucose, carbon 11–labeled Pittsburgh compound B, and FTP PET were performed 52 months prior to death, and magnetic resonance imaging, 50 months prior to death. Brain images were assessed qualitatively for abnormalities blinded to autopsy data. Autopsy was performed using a neurodegenerative research protocol. The FTP standardized uptake value ratios (inferior cerebellar gray reference region) and W-score (age-adjusted z-score) maps were compared with phosphorylated tau immunohistochemical analysis with monoclonal antibody CP13. MAIN OUTCOMES AND MEASURES: Qualitative and quantitative comparisons between antemortem FTP PET and tau pathology at autopsy. RESULTS: Flortaucipir uptake was distributed in a patchy, frontotemporal-predominant pattern that overlapped with regions showing neurodegeneration on magnetic resonance imaging and hypometabolism on 18F-fludeoxyglucose PET. Pathological assessment revealed stage 4 CTE; limbic argyrophilic grain disease; stage 2 limbic-predominant, age-related transactive response DNA-binding protein 43 encephalopathy; and Braak neurofibrillary tangle stage 3. 18F-Flortaucipir W-maps matched areas of high postmortem tau burden in left fusiform and inferior temporal gyri and juxtacortical frontal white matter. High FTP W-scores with low tau burden were found in the basal ganglia, thalamus, motor cortex, and calcarine cortex. No regions with low FTP W-scores corresponded to areas with high pathological tau burden. A modest correlation, which did not reach statistical significance (ρ = 0.35, P = .17), was found between FTP standardized uptake value ratio and tau area fraction at the regional level. CONCLUSIONS AND RELEVANCE: In this patient, FTP PET findings during life showed a modest correspondence with postmortem pathology in CTE. These findings suggest that FTP may have limited utility as a tau biomarker in CTE.</description><identifier>ISSN: 2168-6149</identifier><identifier>EISSN: 2168-6157</identifier><identifier>DOI: 10.1001/jamaneurol.2019.4509</identifier><identifier>PMID: 31904765</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Abnormalities ; Aged ; Alzheimer's disease ; Athletes ; Athletic Injuries - diagnostic imaging ; Athletic Injuries - metabolism ; Athletic Injuries - pathology ; Autopsies ; Autopsy ; Basal ganglia ; Biomarkers ; Brain - diagnostic imaging ; Brain - metabolism ; Brain - pathology ; Brief Report ; Cerebellum ; Chronic traumatic encephalopathy ; Chronic Traumatic Encephalopathy - diagnostic imaging ; Chronic Traumatic Encephalopathy - metabolism ; Chronic Traumatic Encephalopathy - pathology ; Comments ; Correlation analysis ; Cortex (motor) ; DNA-binding protein ; File servers ; Fluorine ; Fluorine isotopes ; Football ; Ganglia ; Humans ; Hypometabolism ; In vivo methods and tests ; Magnetic resonance imaging ; Male ; Medical imaging ; Monoclonal antibodies ; Neurodegeneration ; Neurodegenerative diseases ; Neuroimaging ; Neurology ; Online First ; Pathology ; Positron emission ; Positron emission tomography ; Protocol (computers) ; Qualitative analysis ; Radioactive tracers ; Regional analysis ; Resonance ; Substantia alba ; Tau protein ; tau Proteins - metabolism ; Temporal lobe ; Thalamus ; Tomography</subject><ispartof>Archives of neurology (Chicago), 2020-04, Vol.77 (4), p.517-521</ispartof><rights>Copyright American Medical Association Apr 2020</rights><rights>Copyright 2020 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a455t-18430c9a158f64690531b67762c9dc0bd03bbb058a686d86ba6c180b293969773</citedby><cites>FETCH-LOGICAL-a455t-18430c9a158f64690531b67762c9dc0bd03bbb058a686d86ba6c180b293969773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamaneurology/articlepdf/10.1001/jamaneurol.2019.4509$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2019.4509$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,776,780,881,3327,27901,27902,76231,76234</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31904765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mantyh, William G</creatorcontrib><creatorcontrib>Spina, Salvatore</creatorcontrib><creatorcontrib>Lee, Alex</creatorcontrib><creatorcontrib>Iaccarino, Leonardo</creatorcontrib><creatorcontrib>Soleimani-Meigooni, David</creatorcontrib><creatorcontrib>Tsoy, Elena</creatorcontrib><creatorcontrib>Mellinger, Taylor J</creatorcontrib><creatorcontrib>Grant, Harli</creatorcontrib><creatorcontrib>Vandevrede, Lawren</creatorcontrib><creatorcontrib>La Joie, Renaud</creatorcontrib><creatorcontrib>Lesman-Segev, Orit</creatorcontrib><creatorcontrib>Gaus, Stephanie</creatorcontrib><creatorcontrib>Possin, Katherine L</creatorcontrib><creatorcontrib>Grinberg, Lea T</creatorcontrib><creatorcontrib>Miller, Bruce L</creatorcontrib><creatorcontrib>Seeley, William W</creatorcontrib><creatorcontrib>Rabinovici, Gil D</creatorcontrib><title>Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy</title><title>Archives of neurology (Chicago)</title><addtitle>JAMA Neurol</addtitle><description>IMPORTANCE: Biomarkers for chronic traumatic encephalopathy (CTE) are currently lacking. The radiotracer fluorine F 18–labeled (18F)–flortaucipir (FTP) detects tau pathology in Alzheimer disease, and positron emission tomography (PET) with FTP shows elevated binding in individuals at risk for CTE. No study, however, has assessed the correlation between in vivo FTP PET and postmortem tau in CTE. OBJECTIVE: To assess the regional association between in vivo FTP binding and postmortem tau pathology in a patient with pathologically confirmed CTE. DESIGN, SETTING, AND PARTICIPANTS: A white male former National Football League player with 17 years of US football exposure was clinically diagnosed with traumatic encephalopathy syndrome at a neurology tertiary referral center. 18F-Fludeoxyglucose, carbon 11–labeled Pittsburgh compound B, and FTP PET were performed 52 months prior to death, and magnetic resonance imaging, 50 months prior to death. Brain images were assessed qualitatively for abnormalities blinded to autopsy data. Autopsy was performed using a neurodegenerative research protocol. The FTP standardized uptake value ratios (inferior cerebellar gray reference region) and W-score (age-adjusted z-score) maps were compared with phosphorylated tau immunohistochemical analysis with monoclonal antibody CP13. MAIN OUTCOMES AND MEASURES: Qualitative and quantitative comparisons between antemortem FTP PET and tau pathology at autopsy. RESULTS: Flortaucipir uptake was distributed in a patchy, frontotemporal-predominant pattern that overlapped with regions showing neurodegeneration on magnetic resonance imaging and hypometabolism on 18F-fludeoxyglucose PET. Pathological assessment revealed stage 4 CTE; limbic argyrophilic grain disease; stage 2 limbic-predominant, age-related transactive response DNA-binding protein 43 encephalopathy; and Braak neurofibrillary tangle stage 3. 18F-Flortaucipir W-maps matched areas of high postmortem tau burden in left fusiform and inferior temporal gyri and juxtacortical frontal white matter. High FTP W-scores with low tau burden were found in the basal ganglia, thalamus, motor cortex, and calcarine cortex. No regions with low FTP W-scores corresponded to areas with high pathological tau burden. A modest correlation, which did not reach statistical significance (ρ = 0.35, P = .17), was found between FTP standardized uptake value ratio and tau area fraction at the regional level. CONCLUSIONS AND RELEVANCE: In this patient, FTP PET findings during life showed a modest correspondence with postmortem pathology in CTE. These findings suggest that FTP may have limited utility as a tau biomarker in CTE.</description><subject>Abnormalities</subject><subject>Aged</subject><subject>Alzheimer's disease</subject><subject>Athletes</subject><subject>Athletic Injuries - diagnostic imaging</subject><subject>Athletic Injuries - metabolism</subject><subject>Athletic Injuries - pathology</subject><subject>Autopsies</subject><subject>Autopsy</subject><subject>Basal ganglia</subject><subject>Biomarkers</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Brief Report</subject><subject>Cerebellum</subject><subject>Chronic traumatic encephalopathy</subject><subject>Chronic Traumatic Encephalopathy - diagnostic imaging</subject><subject>Chronic Traumatic Encephalopathy - metabolism</subject><subject>Chronic Traumatic Encephalopathy - pathology</subject><subject>Comments</subject><subject>Correlation analysis</subject><subject>Cortex (motor)</subject><subject>DNA-binding protein</subject><subject>File servers</subject><subject>Fluorine</subject><subject>Fluorine isotopes</subject><subject>Football</subject><subject>Ganglia</subject><subject>Humans</subject><subject>Hypometabolism</subject><subject>In vivo methods and tests</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Monoclonal antibodies</subject><subject>Neurodegeneration</subject><subject>Neurodegenerative diseases</subject><subject>Neuroimaging</subject><subject>Neurology</subject><subject>Online First</subject><subject>Pathology</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Protocol (computers)</subject><subject>Qualitative analysis</subject><subject>Radioactive tracers</subject><subject>Regional analysis</subject><subject>Resonance</subject><subject>Substantia alba</subject><subject>Tau protein</subject><subject>tau Proteins - metabolism</subject><subject>Temporal lobe</subject><subject>Thalamus</subject><subject>Tomography</subject><issn>2168-6149</issn><issn>2168-6157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUVuLEzEUHkRxl3X_gIgEfPGlNZlkcnkRpLS7woIFu_gYMplpJyWTjMmM0H_gz_YMXeslLznku-Sc8xXFG4KXBGPy4Wh6E9opRb8sMVFLVmH1rLguCZcLTirx_FIzdVXc5nzEcCTGjLKXxRUlCjPBq-vi585MaBuzG1MMaN27nB0Uu9jHQzJD5yzauNC4cMjIBWTQJqa-TejxK1RxrI33aOvNCZ6-ubFDWzN20ceDs4Cc0CqGvQNBg1YdfABuu2Sm3oxQrYNth874OIDm9Kp4sTc-t7dP903xuFnvVveLhy93n1efHhaGVdW4IJJRbJUhldxzxhWuKKm5ELy0qrG4bjCt6xpX0nDJG8lrwy2RuC4VVVwJQW-Kj2ffYaqhL9uGMRmvh-R6k046Gqf_RYLr9CH-0FwpLPls8P7JIMXvU5tHDUuzrfcQSJyyLimlal4wAeq7_6jHOKUA4wFLKsGwwBJY7MyyKeac2v2lGYL1nLb-k7ae09Zz2iB7-_cgF9HvbIHw-kwA9QUtRSUkgL8AbmWyyA</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Mantyh, William G</creator><creator>Spina, Salvatore</creator><creator>Lee, Alex</creator><creator>Iaccarino, Leonardo</creator><creator>Soleimani-Meigooni, David</creator><creator>Tsoy, Elena</creator><creator>Mellinger, Taylor J</creator><creator>Grant, Harli</creator><creator>Vandevrede, Lawren</creator><creator>La Joie, Renaud</creator><creator>Lesman-Segev, Orit</creator><creator>Gaus, Stephanie</creator><creator>Possin, Katherine L</creator><creator>Grinberg, Lea T</creator><creator>Miller, Bruce L</creator><creator>Seeley, William W</creator><creator>Rabinovici, Gil D</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200401</creationdate><title>Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy</title><author>Mantyh, William G ; Spina, Salvatore ; Lee, Alex ; Iaccarino, Leonardo ; Soleimani-Meigooni, David ; Tsoy, Elena ; Mellinger, Taylor J ; Grant, Harli ; Vandevrede, Lawren ; La Joie, Renaud ; Lesman-Segev, Orit ; Gaus, Stephanie ; Possin, Katherine L ; Grinberg, Lea T ; Miller, Bruce L ; Seeley, William W ; Rabinovici, Gil D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a455t-18430c9a158f64690531b67762c9dc0bd03bbb058a686d86ba6c180b293969773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abnormalities</topic><topic>Aged</topic><topic>Alzheimer's disease</topic><topic>Athletes</topic><topic>Athletic Injuries - diagnostic imaging</topic><topic>Athletic Injuries - metabolism</topic><topic>Athletic Injuries - pathology</topic><topic>Autopsies</topic><topic>Autopsy</topic><topic>Basal ganglia</topic><topic>Biomarkers</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Brief Report</topic><topic>Cerebellum</topic><topic>Chronic traumatic encephalopathy</topic><topic>Chronic Traumatic Encephalopathy - diagnostic imaging</topic><topic>Chronic Traumatic Encephalopathy - metabolism</topic><topic>Chronic Traumatic Encephalopathy - pathology</topic><topic>Comments</topic><topic>Correlation analysis</topic><topic>Cortex (motor)</topic><topic>DNA-binding protein</topic><topic>File servers</topic><topic>Fluorine</topic><topic>Fluorine isotopes</topic><topic>Football</topic><topic>Ganglia</topic><topic>Humans</topic><topic>Hypometabolism</topic><topic>In vivo methods and tests</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Monoclonal antibodies</topic><topic>Neurodegeneration</topic><topic>Neurodegenerative diseases</topic><topic>Neuroimaging</topic><topic>Neurology</topic><topic>Online First</topic><topic>Pathology</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Protocol (computers)</topic><topic>Qualitative analysis</topic><topic>Radioactive tracers</topic><topic>Regional analysis</topic><topic>Resonance</topic><topic>Substantia alba</topic><topic>Tau protein</topic><topic>tau Proteins - metabolism</topic><topic>Temporal lobe</topic><topic>Thalamus</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mantyh, William G</creatorcontrib><creatorcontrib>Spina, Salvatore</creatorcontrib><creatorcontrib>Lee, Alex</creatorcontrib><creatorcontrib>Iaccarino, Leonardo</creatorcontrib><creatorcontrib>Soleimani-Meigooni, David</creatorcontrib><creatorcontrib>Tsoy, Elena</creatorcontrib><creatorcontrib>Mellinger, Taylor J</creatorcontrib><creatorcontrib>Grant, Harli</creatorcontrib><creatorcontrib>Vandevrede, Lawren</creatorcontrib><creatorcontrib>La Joie, Renaud</creatorcontrib><creatorcontrib>Lesman-Segev, Orit</creatorcontrib><creatorcontrib>Gaus, Stephanie</creatorcontrib><creatorcontrib>Possin, Katherine L</creatorcontrib><creatorcontrib>Grinberg, Lea T</creatorcontrib><creatorcontrib>Miller, Bruce L</creatorcontrib><creatorcontrib>Seeley, William W</creatorcontrib><creatorcontrib>Rabinovici, Gil D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of neurology (Chicago)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mantyh, William G</au><au>Spina, Salvatore</au><au>Lee, Alex</au><au>Iaccarino, Leonardo</au><au>Soleimani-Meigooni, David</au><au>Tsoy, Elena</au><au>Mellinger, Taylor J</au><au>Grant, Harli</au><au>Vandevrede, Lawren</au><au>La Joie, Renaud</au><au>Lesman-Segev, Orit</au><au>Gaus, Stephanie</au><au>Possin, Katherine L</au><au>Grinberg, Lea T</au><au>Miller, Bruce L</au><au>Seeley, William W</au><au>Rabinovici, Gil D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy</atitle><jtitle>Archives of neurology (Chicago)</jtitle><addtitle>JAMA Neurol</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>77</volume><issue>4</issue><spage>517</spage><epage>521</epage><pages>517-521</pages><issn>2168-6149</issn><eissn>2168-6157</eissn><abstract>IMPORTANCE: Biomarkers for chronic traumatic encephalopathy (CTE) are currently lacking. The radiotracer fluorine F 18–labeled (18F)–flortaucipir (FTP) detects tau pathology in Alzheimer disease, and positron emission tomography (PET) with FTP shows elevated binding in individuals at risk for CTE. No study, however, has assessed the correlation between in vivo FTP PET and postmortem tau in CTE. OBJECTIVE: To assess the regional association between in vivo FTP binding and postmortem tau pathology in a patient with pathologically confirmed CTE. DESIGN, SETTING, AND PARTICIPANTS: A white male former National Football League player with 17 years of US football exposure was clinically diagnosed with traumatic encephalopathy syndrome at a neurology tertiary referral center. 18F-Fludeoxyglucose, carbon 11–labeled Pittsburgh compound B, and FTP PET were performed 52 months prior to death, and magnetic resonance imaging, 50 months prior to death. Brain images were assessed qualitatively for abnormalities blinded to autopsy data. Autopsy was performed using a neurodegenerative research protocol. The FTP standardized uptake value ratios (inferior cerebellar gray reference region) and W-score (age-adjusted z-score) maps were compared with phosphorylated tau immunohistochemical analysis with monoclonal antibody CP13. MAIN OUTCOMES AND MEASURES: Qualitative and quantitative comparisons between antemortem FTP PET and tau pathology at autopsy. RESULTS: Flortaucipir uptake was distributed in a patchy, frontotemporal-predominant pattern that overlapped with regions showing neurodegeneration on magnetic resonance imaging and hypometabolism on 18F-fludeoxyglucose PET. Pathological assessment revealed stage 4 CTE; limbic argyrophilic grain disease; stage 2 limbic-predominant, age-related transactive response DNA-binding protein 43 encephalopathy; and Braak neurofibrillary tangle stage 3. 18F-Flortaucipir W-maps matched areas of high postmortem tau burden in left fusiform and inferior temporal gyri and juxtacortical frontal white matter. High FTP W-scores with low tau burden were found in the basal ganglia, thalamus, motor cortex, and calcarine cortex. No regions with low FTP W-scores corresponded to areas with high pathological tau burden. A modest correlation, which did not reach statistical significance (ρ = 0.35, P = .17), was found between FTP standardized uptake value ratio and tau area fraction at the regional level. CONCLUSIONS AND RELEVANCE: In this patient, FTP PET findings during life showed a modest correspondence with postmortem pathology in CTE. These findings suggest that FTP may have limited utility as a tau biomarker in CTE.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>31904765</pmid><doi>10.1001/jamaneurol.2019.4509</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-6149
ispartof Archives of neurology (Chicago), 2020-04, Vol.77 (4), p.517-521
issn 2168-6149
2168-6157
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6990867
source MEDLINE; American Medical Association Journals
subjects Abnormalities
Aged
Alzheimer's disease
Athletes
Athletic Injuries - diagnostic imaging
Athletic Injuries - metabolism
Athletic Injuries - pathology
Autopsies
Autopsy
Basal ganglia
Biomarkers
Brain - diagnostic imaging
Brain - metabolism
Brain - pathology
Brief Report
Cerebellum
Chronic traumatic encephalopathy
Chronic Traumatic Encephalopathy - diagnostic imaging
Chronic Traumatic Encephalopathy - metabolism
Chronic Traumatic Encephalopathy - pathology
Comments
Correlation analysis
Cortex (motor)
DNA-binding protein
File servers
Fluorine
Fluorine isotopes
Football
Ganglia
Humans
Hypometabolism
In vivo methods and tests
Magnetic resonance imaging
Male
Medical imaging
Monoclonal antibodies
Neurodegeneration
Neurodegenerative diseases
Neuroimaging
Neurology
Online First
Pathology
Positron emission
Positron emission tomography
Protocol (computers)
Qualitative analysis
Radioactive tracers
Regional analysis
Resonance
Substantia alba
Tau protein
tau Proteins - metabolism
Temporal lobe
Thalamus
Tomography
title Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A13%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tau%20Positron%20Emission%20Tomographic%20Findings%20in%20a%20Former%20US%20Football%20Player%20With%20Pathologically%20Confirmed%20Chronic%20Traumatic%20Encephalopathy&rft.jtitle=Archives%20of%20neurology%20(Chicago)&rft.au=Mantyh,%20William%20G&rft.date=2020-04-01&rft.volume=77&rft.issue=4&rft.spage=517&rft.epage=521&rft.pages=517-521&rft.issn=2168-6149&rft.eissn=2168-6157&rft_id=info:doi/10.1001/jamaneurol.2019.4509&rft_dat=%3Cproquest_pubme%3E2333931901%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2389740708&rft_id=info:pmid/31904765&rft_ama_id=2757865&rfr_iscdi=true